Belharra Therapeutics

NEWS

Deals

Top I&I Deals So Far in 2024

The size of the global immunology market is projected to nearly double by 2032 to a quarter of a trillion dollars. Here are this year’s standout deals in the space.

August 7, 2024

5 min read

Mollie Barnes

Business

NextGen Class of 2024: Top Life Sciences Startups to Watch This Year

Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.

January 3, 2024

20 min read

BioSpace Editorial Staff

IN THE PRESS

Business

Belharra Therapeutics Announces Broad Collaboration with Genentech to Discover and Develop Novel Medicines Across Multiple Therapeutic Areas

January 4, 2023

3 min read

Business

Belharra Therapeutics Debuts With $130 Million in Funding

January 4, 2023

10 min read

AWARDS

JOBS